Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis A Alshabanat, Z Zafari, O Albanyan, M Dairi, JM FitzGerald PloS one 10 (9), e0136065, 2015 | 342 | 2015 |
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis D Levin, S Bell, R Sund, SA Hartikainen, J Tuomilehto, E Pukkala, ... Diabetologia 58, 493-504, 2015 | 187 | 2015 |
America’s declining well-being, health, and life expectancy: not just a white problem PA Muennig, M Reynolds, DS Fink, Z Zafari, AT Geronimus American journal of public health 108 (12), 1626-1631, 2018 | 135 | 2018 |
Ten-year trends in direct costs of COPD: a population-based study A Khakban, DD Sin, JM FitzGerald, R Ng, Z Zafarí, B McManus, ... Chest 148 (3), 640-646, 2015 | 90 | 2015 |
Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma Z Zafari, M Sadatsafavi, CA Marra, W Chen, JM FitzGerald PLoS One 11 (1), e0146003, 2016 | 68 | 2016 |
Projecting long-term health and economic burden of COPD in the United States Z Zafari, S Li, MN Eakin, M Bellanger, RM Reed Chest 159 (4), 1400-1410, 2021 | 65 | 2021 |
Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study Z Zafari, LD Lynd, JM FitzGerald, M Sadatsafavi Journal of allergy and clinical immunology 134 (4), 908-915. e3, 2014 | 63 | 2014 |
The natural history of severe asthma and influences of early risk factors: a population-based cohort study W Chen, CA Marra, LD Lynd, JM FitzGerald, Z Zafari, M Sadatsafavi Thorax 71 (3), 267-275, 2016 | 57 | 2016 |
Individualized prediction of lung-function decline in chronic obstructive pulmonary disease Z Zafari, DD Sin, DS Postma, CG Löfdahl, J Vonk, S Bryan, S Lam, ... CMAJ 188 (14), 1004-1011, 2016 | 51 | 2016 |
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US Z Zafari, M Sadatsafavi, J Mark FitzGerald, ... Cost Effectiveness and Resource Allocation 16, 1-8, 2018 | 42 | 2018 |
Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information M Sadatsafavi, N Bansback, Z Zafari, M Najafzadeh, C Marra Value in Health 16 (2), 438-448, 2013 | 40 | 2013 |
Population decline in COPD admissions during the COVID-19 pandemic associated with lower burden of community respiratory viral infections JY So, NN O'Hara, B Kenaa, JG Williams, CL deBorja, JF Slejko, Z Zafari, ... The American Journal of Medicine 134 (10), 1252-1259. e3, 2021 | 33 | 2021 |
The projected economic and health burden of sub-optimal asthma control in Canada Z Zafari, M Sadatsafavi, W Chen, JM FitzGerald Respiratory medicine 138, 7-12, 2018 | 32 | 2018 |
The association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic model M Sadatsafavi, DD Sin, Z Zafari, G Criner, JE Connett, S Lazarus, M Han, ... American journal of epidemiology 184 (9), 681-689, 2016 | 32 | 2016 |
A systematic review of health economics simulation models of chronic obstructive pulmonary disease Z Zafari, S Bryan, DD Sin, T Conte, R Khakban, M Sadatsafavi Value in Health 20 (1), 152-162, 2017 | 27 | 2017 |
The cost-effectiveness of bike share expansion to low-income communities in New York city W Yu, C Chen, B Jiao, Z Zafari, P Muennig Journal of urban health 95, 888-898, 2018 | 22 | 2018 |
The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis-a case study of pharmacotherapies for moderate to severe COPD K Thorlund, Z Zafari, E Druyts, EJ Mills, M Sadatsafavi Cost Effectiveness and Resource Allocation 12, 1-9, 2014 | 21 | 2014 |
An evidence-based policy for improving choice in global health access through medical travel K Ruggeri, N Ivanović, J Razum, O Kácha, IG Menezes, Z Zafari, ... Health Policy 122 (12), 1372-1376, 2018 | 17 | 2018 |
Cost-effectiveness of capping freeways for use as parks: the New York Cross-Bronx expressway case study S Kim, Z Zafari, M Bellanger, PA Muennig American journal of public health 108 (3), 379-384, 2018 | 15 | 2018 |
One year effectiveness study of intravitreal aflibercept in neovascular age‐related macular degeneration: a meta‐analysis MY Guo, J Cheng, M Etminan, Z Zafari, D Maberley Acta Ophthalmologica 97 (1), e1-e7, 2019 | 14 | 2019 |